{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:27:06Z","timestamp":1784366826097,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019562","name":"Synoptik-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005929","name":"Danish Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Optometry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.optom.2023.100481","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T23:58:25Z","timestamp":1696118305000},"page":"100481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7556-4658","authenticated-orcid":false,"given":"Anne","family":"Hedengran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-7226","authenticated-orcid":false,"given":"Josefine","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-4980","authenticated-orcid":false,"given":"Pernille","family":"May Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9093-0695","authenticated-orcid":false,"given":"Gerard","family":"Boix-Lemonche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor P.","family":"Utheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene A.","family":"Dartt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2905-9252","authenticated-orcid":false,"given":"Goran","family":"Petrovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-0734","authenticated-orcid":false,"given":"Miriam","family":"Kolko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.optom.2023.100481_bib0001","series-title":"Terminology and Guidelines for Glaucoma","year":"2020"},{"issue":"1","key":"10.1016\/j.optom.2023.100481_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14740338.6.1.45","article-title":"The side effects of the prostaglandin analogues","volume":"6","author":"Holl\u00f3","year":"2007","journal-title":"Expert Opin Drug Saf"},{"issue":"2\u20133","key":"10.1016\/j.optom.2023.100481_bib0003","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/jop.2013.0179","article-title":"Effects of prostaglandin analogues on aqueous humor outflow pathways","volume":"30","author":"Winkler","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.optom.2023.100481_bib0004","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2147\/OPTH.S176605","article-title":"Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study","volume":"12","author":"Economou","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.optom.2023.100481_bib0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bjophthalmol-2012-302121","article-title":"Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma","volume":"97","author":"Rouland","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.optom.2023.100481_bib0006","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma"},{"issue":"7\u20138","key":"10.1016\/j.optom.2023.100481_bib0007","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2298\/SARH1608376R","article-title":"Ocular surface disease incidence in patients with open-angle glaucoma","volume":"144","author":"Radenkovic","year":"2016","journal-title":"Srp Arh Celok Lek"},{"issue":"3","key":"10.1016\/j.optom.2023.100481_bib0008","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.optom.2023.100481_bib0009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.optom.2023.100481_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2016.04.005","article-title":"Goblet cells of the conjunctiva: a review of recent findings","volume":"54","author":"Gipson","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.optom.2023.100481_bib0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0014-4835(03)00204-5","article-title":"Distribution of mucins at the ocular surface","volume":"78","author":"Gipson","year":"2004","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.optom.2023.100481_bib0012","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/aos.15163","article-title":"Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: effect on cultured human conjunctival goblet cells and their physicochemical properties","volume":"100","author":"Hedengran","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.optom.2023.100481_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000892","article-title":"Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops","volume":"6","author":"M\u00fcllertz","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"issue":"3","key":"10.1016\/j.optom.2023.100481_bib0014","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/j.1755-3768.2011.02338.x","article-title":"Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial","volume":"90","author":"Stevens","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.optom.2023.100481_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10792-017-0792-z","article-title":"Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients","volume":"39","author":"Kestelyn","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.optom.2023.100481_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000517845","article-title":"Benzalkonium chloride-preserved anti-glaucomatous eye drops and their effect on human conjunctival goblet cells in vitro","volume":"6","author":"Hedengran","year":"2021","journal-title":"Biomed Hub"},{"issue":"4","key":"10.1016\/j.optom.2023.100481_bib0017","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1167\/iovs.16-20903","article-title":"The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells","volume":"58","author":"Datta","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.optom.2023.100481_bib0018","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/02713683.2011.578781","article-title":"Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells","volume":"36","author":"Brignole-Baudouin","year":"2011","journal-title":"Curr Eye Res"},{"issue":"9","key":"10.1016\/j.optom.2023.100481_bib0019","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1167\/iovs.07-0266","article-title":"In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost","volume":"48","author":"Baudouin","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.optom.2023.100481_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.aanat.2018.12.003","article-title":"In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells","volume":"222","author":"Rath","year":"2019","journal-title":"Ann Anat"},{"issue":"4","key":"10.1016\/j.optom.2023.100481_bib0021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/02713680801971857","article-title":"In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line","volume":"33","author":"Brasnu","year":"2008","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.optom.2023.100481_bib0022","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09273948.2011.618902","article-title":"Roles of IL-8 in ocular inflammations: a review","volume":"19","author":"Ghasemi","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.optom.2023.100481_bib0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pathophys.2017.05.005","article-title":"Interleukin-6 participation in pathology of ocular diseases","volume":"24","author":"Zahir-Jouzdani","year":"2017","journal-title":"Pathophysiology"},{"issue":"9","key":"10.1016\/j.optom.2023.100481_bib0024","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1167\/iovs.11-9417","article-title":"Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease","volume":"53","author":"Na","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.optom.2023.100481_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/939602","article-title":"Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome","author":"Cvenkel","year":"2010","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.optom.2023.100481_bib0026","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.optom.2023.100481_bib0027","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/ceo.13814","article-title":"Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: a 2-year randomized evaluation study","volume":"48","author":"Mohammed","year":"2020","journal-title":"Clin Experiment Ophthalmol"},{"issue":"4","key":"10.1016\/j.optom.2023.100481_bib0028","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jtos.2017.03.004","article-title":"Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost","volume":"15","author":"Martinez-de-la-Casa","year":"2017","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.optom.2023.100481_bib0029","first-page":"4025","article-title":"Analysis of the effects of preservative-free tafluprost on the tear proteome","volume":"8","author":"Funke","year":"2016","journal-title":"Am J Transl Res"},{"issue":"9","key":"10.1016\/j.optom.2023.100481_bib0030","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.19082\/2954","article-title":"Adherence to treatment in patients with open-angle glaucoma and its related factors","volume":"8","author":"Movahedinejad","year":"2016","journal-title":"Electron Physician"},{"key":"10.1016\/j.optom.2023.100481_bib0031","first-page":"40","article-title":"In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis)","volume":"110","author":"Baudouin","year":"2012","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"10.1016\/j.optom.2023.100481_bib0032","doi-asserted-by":"crossref","first-page":"e50180","DOI":"10.1371\/journal.pone.0050180","article-title":"A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits","volume":"7","author":"Brignole-Baudouin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.optom.2023.100481_bib0033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tiv.2017.02.006","article-title":"Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma","volume":"41","author":"Bouchemi","year":"2017","journal-title":"Toxicol In Vitro"}],"container-title":["Journal of Optometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888429623000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888429623000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:13:59Z","timestamp":1761822839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888429623000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1888429623000298"],"URL":"https:\/\/doi.org\/10.1016\/j.optom.2023.100481","relation":{},"ISSN":["1888-4296"],"issn-type":[{"value":"1888-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Optometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.optom.2023.100481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Spanish General Council of Optometry. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100481"}}